Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Clot Management Devices Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Clot Management Devices Trends and Forecast

The future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets. The global clot management devices market is expected to reach an estimated $2.5 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.
Clot Management Devices Trends and Forecast

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Clot Management Devices by Segment

Clot Management Devices by Segment

The study includes a forecast for the global clot management devices by product, percutaneous thrombectomy devices type, end use, and region.

Clot Management Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:


• Neurovascular Embolectomy Devices
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter-Directed Thrombolysis (CDT) Devices
• Inferior Vena Cava Filters (IVCF)

Clot Management Devices Market by Percutaneous Thrombectomy Devices Type [Shipment Analysis by Value from 2018 to 2030]:


• Aspiration Thrombectomy Devices
• Percutaneous Mechanical Thrombectomy Devices

Clot Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:


• Diagnostic Centers
• Hospitals
• Others

Clot Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Clot Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clot management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clot management devices companies profiled in this report include-
• Medtronic
• Boston Scientific Corporation
• iVascular SLU
• Teleflex
• Edwards Lifesciences Corporation
• LeMaitre Vascular
• Vascular Solutions
• Straub Medical
• Cook Medical
• DePuy Synthes

Clot Management Devices Market Insights

Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.
Within this market, hospitals will remain the largest segment due to increasing adoption of specialized departments, advanced labs, and operating rooms in hospitals for cardiovascular treatments.
APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Features of the Global Clot Management Devices Market

Market Size Estimates: Clot management devices market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Clot management devices market size by product, percutaneous thrombectomy devices type, end use, and region in terms of value ($B).
Regional Analysis: Clot management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, percutaneous thrombectomy devices types, end uses, and regions for the clot management devices market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clot management devices market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the clot management devices market size?
Answer: The global clot management devices market is expected to reach an estimated $2.5 billion by 2030.
Q.2 What is the growth forecast for clot management devices market?
Answer: The global clot management devices market is expected to grow with a CAGR of 5.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the clot management devices market?
Answer: The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.
Q4. What are the major segments for clot management devices market?
Answer: The future of the clot management devices market looks promising with opportunities in the diagnostic centers, and hospitals markets.future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets.
Q5. Who are the key clot management devices market companies?
Answer: Some of the key clot management devices companies are as follows:
• Medtronic
• Boston Scientific Corporation
• iVascular SLU
• Teleflex
• Edwards Lifesciences Corporation
• LeMaitre Vascular
• Vascular Solutions
• Straub Medical
• Cook Medical
• DePuy Synthes
Q6. Which clot management devices market segment will be the largest in future?
Answer: Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.
Q7. In clot management devices market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the clot management devices market by product (neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices,catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF)), percutaneous thrombectomy devices type (aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices), end use (diagnostic centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Clot Management Devices Market, Clot Management Devices Market Size, Clot Management Devices Market Growth, Clot Management Devices Market Analysis, Clot Management Devices Market Report, Clot Management Devices Market Share, Clot Management Devices Market Trends, Clot Management Devices Market Forecast, Clot Management Devices Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Clot Management Devices Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Clot Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Clot Management Devices Market by Product
3.3.1: Neurovascular Embolectomy Devices
3.3.2: Embolectomy Balloon Catheters
3.3.3: Percutaneous Thrombectomy Devices
3.3.4: Catheter-Directed Thrombolysis (CDT) Devices
3.3.5: Inferior Vena Cava Filters (IVCF)
3.4: Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
3.4.1: Aspiration Thrombectomy Devices
3.4.2: Percutaneous Mechanical Thrombectomy Devices
3.5: Global Clot Management Devices Market by End Use
3.5.1: Diagnostic Centers
3.5.2: Hospitals
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Clot Management Devices Market by Region
4.2: North American Clot Management Devices Market
4.2.1: North American Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
4.2.2: North American Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
4.3: European Clot Management Devices Market
4.3.1: European Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
4.3.2: European Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
4.4: APAC Clot Management Devices Market
4.4.1: APAC Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
4.4.2: APAC Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
4.5: ROW Clot Management Devices Market
4.5.1: ROW Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
4.5.2: ROW Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Clot Management Devices Market by Product
6.1.2: Growth Opportunities for the Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
6.1.3: Growth Opportunities for the Global Clot Management Devices Market by End Use
6.1.4: Growth Opportunities for the Global Clot Management Devices Market by Region
6.2: Emerging Trends in the Global Clot Management Devices Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Clot Management Devices Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clot Management Devices Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Medtronic
7.2: Boston Scientific Corporation
7.3: iVascular SLU
7.4: Teleflex
7.5: Edwards Lifesciences Corporation
7.6: LeMaitre Vascular
7.7: Vascular Solutions
7.8: Straub Medical
7.9: Cook Medical
7.10: DePuy Synthes
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Clot Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.